These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7596357)

  • 1. Somatic cell mutation frequency at the HPRT, T-cell antigen receptor and glycophorin A loci in Cockayne syndrome.
    Lin YW; Kubota M; Hirota H; Furusho K; Tomiwa K; Ochi J; Kasahara Y; Sasaki H; Ohta S
    Mutat Res; 1995 Jul; 337(1):49-55. PubMed ID: 7596357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation.
    Hirota H; Kubota M; Adachi S; Okuda A; Lin YW; Bessho R; Wakazono Y; Matsubara K; Kuwakado K; Akiyama Y
    Mutat Res; 1994 Sep; 315(2):95-103. PubMed ID: 7521002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies.
    Bigbee WL; Fuscoe JC; Grant SG; Jones IM; Gorvad AE; Harrington-Brock K; Strout CL; Thomas CB; Moore MM
    Mutat Res; 1998 Feb; 397(2):119-36. PubMed ID: 9541637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequencies of HPRT- lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors.
    Sala-Trepat M; Boyse J; Richard P; Papadopoulo D; Moustacchi E
    Mutat Res; 1993 Sep; 289(1):115-26. PubMed ID: 7689157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal mutation frequencies of somatic cells in patients receiving growth hormone therapy.
    Lin YW; Kubota M; Wakazono Y; Hirota H; Okuda A; Bessho R; Usami I; Kataoka A; Yamanaka C; Akiyama Y; Furusho K
    Mutat Res; 1996 Jan; 362(1):97-103. PubMed ID: 8538654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
    Wijnhoven SW; Kool HJ; van Oostrom CT; Beems RB; Mullenders LH; van Zeeland AA; van der Horst GT; Vrieling H; van Steeg H
    Cancer Res; 2000 Oct; 60(20):5681-7. PubMed ID: 11059760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in long survivors of pediatric acute lymphoblastic leukemia patients: late effects of cancer chemotherapy.
    Koishi S; Kubota M; Sawada M; Hirota H; Hashimoto H; Lin YW; Watanabe K; Usami I; Akiyama Y; Furusho K
    Mutat Res; 1998 Dec; 422(2):213-22. PubMed ID: 9838123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts.
    Perera FP; Tang DL; O'Neill JP; Bigbee WL; Albertini RJ; Santella R; Ottman R; Tsai WY; Dickey C; Mooney LA
    Carcinogenesis; 1993 May; 14(5):969-73. PubMed ID: 8504491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mutant frequencies at the hprt and the T-cell receptor loci in pediatric cancer patients before treatment.
    Sawada M; Kubota M; Lin YW; Watanabe K; Koishi S; Usami I; Akiyama Y; Matsumura T; Furusho K
    Mutat Res; 1998 Feb; 397(2):337-43. PubMed ID: 9541658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy.
    Sawada M; Kubota M; Lin YW; Watanabe K; Koishi S; Usami I; Akiyama Y; Matsumura T; Furusho K
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):711-7. PubMed ID: 9718224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical background somatic mutant frequencies at the HPRT locus in children and adults with Down syndrome.
    Finette BA; Rood B; Poseno T; Vacek P; Pueschel S; Homans AC
    Mutat Res; 1998 Jul; 403(1-2):35-43. PubMed ID: 9726004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analyses of in vivo hypoxanthine-guanine phosphoribosyltransferase mutations in human T-lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T-lymphocytes in vivo.
    Nicklas JA; O'Neill JP; Sullivan LM; Hunter TC; Allegretta M; Chastenay BF; Libbus BL; Albertini RJ
    Environ Mol Mutagen; 1988; 12(3):271-84. PubMed ID: 3262508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation frequency in human blood cells increases with age.
    Akiyama M; Kyoizumi S; Hirai Y; Kusunoki Y; Iwamoto KS; Nakamura N
    Mutat Res; 1995 Oct; 338(1-6):141-9. PubMed ID: 7565869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of somatic mutations in human umbilical cord blood to maternal environments.
    Manchester DK; Nicklas JA; O'Neill JP; Lippert MJ; Grant SG; Langlois RG; Moore DH; Jensen RH; Albertini RJ; Bigbee WL
    Environ Mol Mutagen; 1995; 26(3):203-12. PubMed ID: 7588645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.
    Grant DJ; Hall IJ; Eastmond DA; Jones IM; Bell DA
    Mutat Res; 2004 May; 560(1):1-10. PubMed ID: 15099818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic cell mutation in pediatric patients undergoing allogeneic bone marrow transplantation.
    Hamahata K; Kubota M; Usami I; Lin YW; Shimizu K; Morimoto A; Nakahata T
    Mutat Res; 2002 May; 517(1-2):21-8. PubMed ID: 12034305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple biological markers in germ cell tumor patients treated with platinum-based chemotherapy.
    Perera FP; Motzer RJ; Tang D; Reed E; Parker R; Warburton D; O'Neill P; Albertini R; Bigbee WL; Jensen RH
    Cancer Res; 1992 Jul; 52(13):3558-65. PubMed ID: 1319825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated in vivo frequencies of mutant T cells with altered functional expression of the T-cell receptor or hypoxanthine phosphoribosyltransferase genes in p53-deficient mice.
    Suzuki T; Kusunoki Y; Tsuyama N; Ohnishi H; Seyama T; Kyoizumi S
    Mutat Res; 2001 Nov; 483(1-2):13-7. PubMed ID: 11600127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercorrelations and sources of variability in three mutagenicity assays: a population-based study.
    Radack K; Martin V; Wones R; Buncher R; Pinney S; Mandell K
    Mutat Res; 1996 Mar; 350(2):295-306. PubMed ID: 8600359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of mutation frequency at the HPRT locus in peripheral lymphocytes. Is this a good method to evaluate a cancer risk in pediatric patients?
    Lin YW; Kubota M; Akiyama Y; Sawada M; Furusho K
    Adv Exp Med Biol; 1998; 431():681-6. PubMed ID: 9598152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.